Dr. Boja is a health scientist who will support OHI’s precisionFDA initiative and other informatics endeavors. Prior to joining OHI, she was a Program Director at the Office of Cancer Clinical Proteomic Research, NCI, NIH, providing scientific expertise and leadership in managing the Clinical Proteomic Tumor Analysis Consortium program.
Join 60,000 others in government and subscribe to
our newsletter — a round-up of the best digital news in government
and across our field.